Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax™ GAITHERSBURG, Md., Dec. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today the submission of an application to the U.S. Food and Drug Administration (FDA) for...